Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01051336 · ClinicalTrials.gov registry record · Phase 1
Safety and Tolerability Study of the Taris Placebo System
A Phase 1 study, sponsored by TARIS Biomedical.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT01051336 is a Phase 1 study that has completed, run by TARIS Biomedical. The registered enrollment target is 10 participants.
The verdict
NCT01051336, a Phase 1 study, has completed, sponsored by TARIS Biomedical.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The aim of this protocol is to evaluate the tolerability of the Taris placebo system for the development program and to provide key safety and tolerability data for the Taris platform.
Interventions
- PROCEDURE Sham Procedure
- DEVICE TARIS Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-10 |
| Est. Completion | 2009-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01051336
The ClinicalTrials.gov registry entry for NCT01051336 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TARIS Biomedical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Procedure is the first listed.
NCT01051336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01051336 about?
NCT01051336 is a clinical study titled "Safety and Tolerability Study of the Taris Placebo System". The aim of this protocol is to evaluate the tolerability of the Taris placebo system for the development program and to provide key safety and tolerability data for the Taris platform.
What is the current status of trial NCT01051336?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2009-10. Estimated completion is 2009-11.
What interventions are being tested in trial NCT01051336?
The interventions under investigation include: Sham Procedure (PROCEDURE), TARIS Placebo (DEVICE).
Who is sponsoring clinical trial NCT01051336?
This trial is sponsored by TARIS Biomedical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.